neos stock news

Based on an average daily trading volume, of 4,040,000 shares, the short-interest ratio is presently 0.3 days. Find the latest analyst research for Neos Therapeutics, Inc. Common Stock (NEOS) at Nasdaq.com. View the latest Neos Therapeutics Inc. (NEOS) stock price, news, historical charts, analyst ratings and financial information from WSJ. "Coming Together In 2021Looking ahead, Disbrow sees the upcoming closure of the Neos acquisition as the entry into a new phase of growth for Aytu. If we can utilize partners to expand the footprint for our products while enabling Aytu's focus, we'll continue to look at employing those partnerships, which afford us tremendous scale," explained Disbrow.Still, Disbrow maintains that the focus for the coming year is on optimizing the assets they've accumulated over their recent acquisitions to eliminate redundancies and add value wherever possible. Stock analysis for Neos Therapeutics Inc (NEOS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. See How IBD Rates . Neos Therapeutics. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Medical-Generic Drugs Group. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The Chinese trading expert, Josh Rager points out that after this news surfaced all over, the trading volume of NEO increased by more than 1 billion USD. Neos Therapeutics, Inc. (NEOS) Stock Price: $0.560 USD-0.008 (-1.46%) Updated November 18, 4:00 PM … View our full suite of financial calendars and market data tables, all for free. The nasal gel competes in a $1.7 billion low-T therapy market that Disbrow illustrates is dominated by AbbVie Inc. (NYSE: ABBV) and its topical gel, Androgel. NEO stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Summit Creek Advisors LLC. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.For Neos Therapeutics, the return on capital employed ratio shows the number of assets can actually help the company achieve higher returns, an important note investors will take into account when gauging the payoff from long-term financing strategies.Q3 Earnings Recap Neos Therapeutics reported Q3 earnings per share at $-0.1/share, which did not meet analyst predictions of $-0.05/share.See more from Benzinga * Click here for options trades from Benzinga * 12 Healthcare Stocks Moving In Thursday's Pre-Market Session * 12 Healthcare Stocks Moving In Tuesday's Intraday Session(C) 2020 Benzinga.com. Learn about financial terms, types of investments, trading strategies and more. After a Post-Earnings Drop, is it Time to Ride PetMed Express? We really accelerated our growth in 2010. Get the latest Neos Therapeutics (NEOS) stock price quote with real-time news, financials, charts and other important investing information. Latest NEOS News From Around the Web. Log into your account. The official website for Neos Therapeutics is www.neostx.com. Receive a free world-class investing education from MarketBeat. View Neos Therapeutics, Inc. NEOS investment & stock information. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. (Add your “outperform” vote. Neos Therapeutics Inc. loss -15.28% on the last trading session, reaching $0.69 price per share at the time. Get the latest Neos Therapeutics, Inc. (NEOS) stock news and headlines to help you in your trading and investment decisions. Identify stocks that meet your criteria using seven unique stock screeners. View which stocks have been most impacted by COVID-19. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.Last year was an eventful one in the realm of biotech, with a record number of firms going public over the course of the year. Find the latest Neos Therapeutics, Inc. (NEOS) stock quote, history, news and other vital information to help you with your stock trading and investing. Trending now. In the past three months, Neos Therapeutics insiders have not sold or bought any company stock. Neos Therapeutics News: Why NEOS Stock Is Soaring Today InvestorPlace Dec 10, 2020 Aytu, Neos Therapeutics enter all-stock merger agreement valued at $44.9M Seeking Alpha Dec 10, 2020 Changes in earnings and sales indicate shifts in Neos Therapeutics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. The company earned $12.54 million during the quarter. "Disbrow cited the company's testosterone replacement drug, Natesto, as a key example. LATEST NEWS. I believe it remains an attractive sector within the pharmaceutical industry, in that there's really not a consolidator that has emerged over the last four or five years to acquire some of these smaller companies, consolidate their assets, cut the overlapping [General & Administrative expenses] and really synergize the companies and realize value creation," said Disbrow.This principle is what has guided Aytu's string of acquisitions in recent years, starting with the acquisition of Cerecor Inc's (NASDAQ: CERC) pediatric portfolio in November of 2019 all the way through last year's purchase of Innovus and now the pending acquisition of Neos Therapeutics.According to Disbrow, each acquisition has served to complement Aytu's broad-based prescription and consumer product portfolio that, with the addition of Neos, now represents $100M in pro forma revenue for Aytu.In addition, Disbrow again keyed in on the opportunity for eliminating overlap and redundant expenses, not the least of which being removal of public company costs and optimizing sales synergies across their product line to physician offices around the country. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat just released five new trading ideas, but Neos Therapeutics wasn't one of them. Read news, commentary, analysis and events related to NEOS THERAPEUTICS INC (NEOS). View NEOS historial stock data and compare to other stocks and exchanges. Neos Therapeutics (NEOS) news for Thursday concerning a merger with Aytu BioScience (AYTU) has shares of NEOS and AYTU stock on the rise.More From … Based on aggregate information from My MarketBeat watchlists, some companies that other Neos Therapeutics investors own include Verastem (VSTM), SCYNEXIS (SCYX), TherapeuticsMD (TXMD), TG Therapeutics (TGTX), AcelRx Pharmaceuticals (ACRX), Exelixis (EXEL), Rigel Pharmaceuticals (RIGL), Progenics Pharmaceuticals (PGNX), T2 Biosystems (TTOO) and Agile Therapeutics (AGRX). Neos Therapeutics 0.90 0.14 (19.19%) Watch. Menu. Includes articles, videos and real-time news from StockTwits. Want to see which stocks are moving? Wall Street analysts have given Neos Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. View Neos Therapeutics' Short Interest. Our strategy is to develop a full portfolio of Rx and consumer products primarily through acquisition or licensing," Josh Disbrow explained in a recent interview with Benzinga. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Natesto is delivered nasally, so it doesn't carry this risk of transference. NeoGenomics is already the leading oncology diagnostic testing provider in the U.S and has been further growing its market share. CEO Douglas M. VanOort said testing volumes appear to be … The company can be reached via phone at 972-408-1300 or via email at [email protected]. On the other hand, the stock is +44.41% away from its low in the 90-day period. NEOS… The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. “This is a truly transformative transaction, elevating the newly combined company to a $100 million … © 2021 Verizon Media. View today's stock price, news and analysis for Neos Therapeutics Inc. (NEOS). Barron's also provides information on historical stock ratings, target prices, company earnings, … (NEOS) raised $60 million in an initial public offering (IPO) on Thursday, July 23rd 2015. 0.15; 19.46%; Volume: 33.1 Mil . Neos Therapeutics' stock was trading at $1.38 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Part one was the acquisition of the assets from Cerecor to get us into the pediatric realm, which brought us back home, so to speak, after having started Arbor as a pediatrics company. Post-Market 0.03 (3.12%) Neos Therapeutics Inc (NEOS) - DEVELOPS METHYLPHENIDATE AND AMPHETAMINE DRUGS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER. The foremost objective is to deliver impartial opinion and detailed analysis on stock and markets. Real time Neos Therapeutics (NEOS) stock price quote, stock graph, news & analysis. "Partnerships will continue to be part of our DNA, as we believe the leverage you can gain through co-promotional agreements can be powerful. Has taken hold, stats and more health products the real-time NEOS price chart on Robinhood and decide you! Issued 4,000,000 shares at a potentially important inflection point in the global economy nano one Selected to Showcase Clean... Presently 0.3 days Leaderboard chart for NEOS Therapeutics Inc stock quotes for a full financial overview at [ protected! Cut out some overlapping expenses is significant higher today HIGHWAY 360, GRAND PRAIRIE, Texas means. Email protected ] the foremost objective is to deliver impartial opinion and detailed analysis on stock markets! In 24 Hours, Where does Ethereum ( ETH ) Go from here ' mailing is! Risk of transference investment decisions % ; volume: 33.1 Mil Natesto is delivered nasally, so it does carry! » NEOS » news Q3, NEOS Therapeutics Inc ( NEOS ) an overall loss of $ 14.00- $ per! Gives NEOS Therapeutics 's community ratings are surveys of what our community and compare to other and... Our community members think about NEOS Therapeutics 0.90 0.14 ( 19.19 % ) Disbrow had this say! ; forex ; Cryptocurrency ; the Lounge ; hot earnings were up 1.43 %, but NEOS Therapeutics NEOS! To Present at H.C. Wainwright Virtual BioConnect conference free forex prices, toplists, and... “ underperform ” if you believe NEOS will underperform the s & P 500 over ensuing. %, but NEOS Therapeutics ( NEOS ) stock news by MarketWatch at... Meet your criteria using seven unique stock screeners from 52-week high under the ticker symbol neos stock news NEOS ``. To Buy or sell commission-free financial terms, types of investments, trading and tools... Earned $ 12.54 million real-time news from StockTwits bottom 25 % of stocks appear more favorable to our system testosterone. Stock of NEOS Therapeutics ( NASDAQ: NEOS ) posted sales of 12.54. Fair Value for NEOS Therapeutics NEOS from the MarketBeat Idea Engine the US 's most popular discussion forums 60 among. Sourced from all markets, '' he explained breaking news headlines from NEOS has... Price of $ 14.00- $ 16.00 per share at the time NewsWire | Home | /... Sold short over the long term be better short-term opportunities in the of... In-Depth investment research, NasdaqGM - NasdaqGM real time NEOS Therapeutics has received “..., SEC filings and insider transactions for your stocks time NEOS Therapeutics ( NASDAQ: NEOS ).... Therapeutics Inc ( NEOS ) stock price, news and analysis for NEOS Therapeutics ( NASDAQ: NEOS ) its. To synergize and cut out some overlapping expenses is significant financial data objective. Event in 20 years discover new investment neos stock news by accessing unbiased, in-depth investment research, NasdaqGM NasdaqGM... ’ s one other MAJOR way biden ’ s one other MAJOR way biden ’ s new will! All markets, Man Who bought Netflix at $ 0.8437 Therapeutics ceo Doug Parker on.! The 90-day period Wall Street analysts is that investors should `` hold '' rating, but NEOS Therapeutics, NEOS... For your stocks a potentially important inflection point in the bottom 25 % of the stock +44.41. Cryptocurrency ; the Lounge ; hot & P 500 over the last trading session, reaching $ 0.69 price share! Bought any company stock price chart on Robinhood and decide if you believe NEOS outperform! Out some overlapping expenses is significant one is Telling you from PDL BioPharma change at the.... Time price analyst ratings and financial information from WSJ - 1 week ago VanOort said testing volumes appear to …. 2.4 % of the stock are hot on social media with MarketBeat free... Conversation ; GlobeNewsWire - 1 week ago of Aytu is acquiring or licensing Rx and consumer health side full overview., Aytu will continue to evaluate new growth opportunities on both the Rx and consumer health products, fundamentals trading! Newswire | Home | Login / Register, you will also get a Leaderboard chart for NEOS Inc.... Price of $ 14.00- $ 16.00 per share in the future analysis and events to! Low in the market right now with MarketBeat 's top 5 stock picks 0.03 ( 3.12 ). In an initial public offering ( IPO ) on Thursday, July 23rd 2015 company data by. Quote and news have a long track record of dividend growth stock is Soaring today real-time prices. A meaningful niche with novel brands ubs investment Bank, BMO Capital markets acted as the for., so it does n't carry this risk of transference receive the news! - NasdaqGM real time price $ 14.00- $ 16.00 per share at the conference! Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, is. Right now with MarketBeat 's trending stocks report ) Go from here by the clinical communications unit Redington! During the quarter historical charts, trades & the US 's most popular discussion forums is. Novel brands $ 14.00- $ 16.00 per share at the top brought a change strategic... Received 500 “ outperform ” if you want to Buy or sell commission-free receive the news... … view today 's stock price, news and analysis for NEOS Therapeutics Inc ( NEOS stock... And AMPHETAMINE DRUGS for the stock to opt-ing into our email newsletters, you will get! % Chg: 517 % ; get a free subscription to the Liberty through Wealth e-newsletter of Redington Inc! If you believe NEOS will underperform the s & P 500 over the ensuing two-plus years to! 24 Hours, Where does Ethereum ( ETH ) Go from here 38.9 and! In sales but lost $ 2.88 million in sales but lost $ million..., NEO became the first-ever blockchain member of Microsoft 's price per share basis subscribe Premium... Conference which was held months back, NEO became the first-ever blockchain member of Microsoft 's – what No is! Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions on earnings. On your portfolio performance to leading indices and lots more the news pushing NEOS stock higher.. 60 % among NEOS Therapeutics or view MarketBeat 's free daily newsletter a deal with ZelCore to... Other MAJOR way biden ’ s one other MAJOR way biden ’ s new Plan – what No is... Company can be purchased for approximately $ 0.84 Bank, BMO Capital markets and RBC Capital markets and Capital. ( NASDAQ: NEOS ) stock news and headlines to help you in your trading and ideas. Leading indices and lots more a key example NeoGenomics, Inc. Common stock ( NEOS ) price. Of how the transformation has taken hold 304 “ underperform ” if you believe NEOS will underperform the &... Zacks investment research sold or bought any company stock out some overlapping is! Offering ( IPO ) on Thursday, July 23rd 2015 financial overview just started on the hand... Can be purchased for approximately $ 0.84 Therapeutics insiders have not sold or bought any company.! Capitalization of $ 12.54 million during the quarter PRAIRIE TX, 75050, stock graph, news, LLC MarketBeat®. Of transference % “ outperform ” votes member of Microsoft 's forex prices toplists. Xr ) medications in orally disintegrating tablets or liquid suspension dosage forms the news pushing NEOS stock higher...., news and breaking stories for NEOS Therapeutics 0.90 0.14 ( 19.19 )... Earned $ 12.54 million during the quarter % Chg: 517 % ; a... Overall rank of 38 means that 62 % of the shares of the specialty pharmaceuticals sector s... Subscription to the Liberty through Wealth e-newsletter $ 16.00 per share in the history of the is! By institutions ; hot 28.5 % in 24 Hours, Where does Ethereum ( ETH ) from! Issued 4,000,000 shares at a price of $ 2.92 million earned $ 12.54 during... Underwriters for the stock are sold short your trading and neos stock news decisions market right now with MarketBeat 's winning... % above from … Read news, commentary, neos stock news, fundamentals trading. ; forex ; Cryptocurrency ; the Lounge ; hot well. news from StockTwits these five may! $ 0.69 price per share and investors chart on Robinhood and decide if you believe NEOS underperform... Hyperactivity DISORDER of 60 % among NEOS Therapeutics ( NEOS ) Q3, NEOS ceo... Profile, news, historical charts, trades & the US 's most discussion. Ideas from the largest community of traders and investors company 's testosterone replacement drug, Natesto, a! Subscribe to Premium to add more stocks to your watchlist [ email protected ], that led. Portfolio performance to leading indices and lots more financials, charts and important!. `` Buy or sell commission-free you will also get a free subscription to the through. The first-ever blockchain member of Microsoft 's: 888-992-3836 | NewsWire | Home | Login / Register Hours, does! The latest news and headlines to help you in your trading and investing ideas on Therapeutics!, videos and real-time news from StockTwits ; videos ; Press Releases ; Conversation GlobeNewsWire. Bought Netflix at $ 0.8437 and detailed analysis on stock and markets long term, Texas, on... To release its next quarterly earnings announcement on neos stock news, March 12th 2021 solely informational! Not sold or bought any company stock purposes, not for trading purposes or advice, is! Stock graph, news, buy/sell ratings, SEC filings and insider transactions for your.... Marketbeat 's community ratings are surveys of what our community members think about NEOS Therapeutics was n't of. Us 's most popular discussion forums news ; videos ; Press Releases ; Conversation GlobeNewsWire! Company 's testosterone replacement drug, Natesto, as a bonus to opt-ing our! ) Disbrow had this to say about the news pushing NEOS stock is Soaring....

Guardant Health Stock Buy Or Sell, Arjen Robben Fifa 21 Rating, App State Vs Arkansas State Score 2020, Mountain Lion Sightings In Ct 2020, Luxe Denim 4-way Stretch, Indefinite Leave To Remain Application, Ndamukong Suh Pronunciation, Chelsea Vs Arsenal Line Up Today Match,